Literature DB >> 23301535

What is the current practice of medicines reconciliation in children nationally in the UK?

Chi Huynh1, Yogini Jani, Ian Chi Kei Wong, Bhavika Dewchand, Stephen Tomlin.   

Abstract

INTRODUCTION: The National Institute for Health and Clinical Excellence/National Patient Safety Agency (NICE/NPSA) guidelines for medicines reconciliation (MR) on admission to hospital in adult inpatients were introduced in 2007, but they excluded children less than 16 years of age.
METHOD: We conducted a survey of 98 paediatric pharmacists (each from a different hospital) to find out what the current practice of MR in children is in the UK. KEY
FINDINGS: Responses showed that 67% (43/64) of pharmacists surveyed carried out MR in all children at admission and only a third 34% (22/64) had policies for MR in children. Of the respondents who did not carry out MR in all children, 80% (4/5) responded that they did so in selected children. Pharmacists considered themselves the most appropriate profession for carrying out MR. When asked whether the NICE guidance should be expanded to include children, 98% (54/55) of the respondents answered 'yes'.
CONCLUSION: In conclusion, the findings suggest that MR is being conducted inconsistently in children and most paediatric pharmacists would like national guidance to be expanded to include children.
© 2012 The Authors. IJPP © 2012 Royal Pharmaceutical Society.

Entities:  

Mesh:

Year:  2012        PMID: 23301535     DOI: 10.1111/j.2042-7174.2012.00218.x

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  2 in total

Review 1.  Medication discrepancies at transitions in pediatrics: a review of the literature.

Authors:  Chi Huynh; Ian C K Wong; Stephen Tomlin; David Terry; Anthony Sinclair; Keith Wilson; Yogini Jani
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

2.  Epidemiology of medication-related problems in children with kidney disease.

Authors:  Norkasihan Ibrahim; Ian Chi Kei Wong; Stephen Tomlin; Manish D Sinha; Lesley Rees; Yogini Jani
Journal:  Pediatr Nephrol       Date:  2014-10-29       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.